PATENTS GRANTED IN
118 Countries
Worldwide footprint
ReoStem – A TRULY GLOBAL TECHNOLOGY
With WIPO No. WO2007 141657 A2, published on December 13, 2007, ReoStem technology has been granted in 118 countries.
Algeria
Australia
Canada
Georgia
Israel
Indonesia
Japan
Liberia
Malaysia
Mexico
Mongolia
Morocco
New Zealand
Nigeria
North Korea
Philippines
Singapore
South Africa
South Korea
Swaziland
Ukraine
USA (8/9)
OAPI (17 countries)
- Benin
- Burkina Faso
- Cameroon
- Central African Republic
- Chad
- Congo
- Ivory Coast
- Equatorial Guinea
- Gabon
- Guinea
- Guinea-Bissau
- Mali
- Mauritania
- Niger
- Senegal
- Togo
- Comoros
EPO (38 countries)
- Albania
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czech Republic
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Croatia
- Hungary
- Ireland
- Iceland
- Italy
- Liechtenstein
- Lithuania
- Luxembourg
- Latvia
- Monaco
- North Macedonia
- Malta
- Netherlands
- Norway
- Poland
- Portugal
- Romania
- Serbia
- Sweden
- Slovenia
- Slovakia
- San Marino
- Turkey
ARIPO (31 countries)
- Botswana
- Gambia
- Ghana
- Kenya
- Lesotho
- Liberia
- Malawi
- Mozambique
- Namibia
- Rwanda
- Sao Tome and Principe
- Sierra Leone
- Somalia
- Sudan
- Swaziland
- Tanzania
- Uganda
- Zambia
- Zimbabwe
- Algeria
- Angola
- Burundi
- Egypt
- Eritrea
- Ethiopia
- Libya
- Mauritius
- Nigeria
- Seychelles
- South Africa
- Tunisia
Eurasian Patent (9 countries)
- Turkmenistan
- Republic of Belarus
- Republic of Tajikistan
- Russian Federation
- Republic of Kazakhstan
- Republic of Azerbaijan
- Kyrgyz Republic
- Republic of Moldova
- Republic of Armenia
House of Lords
ReoStem technology and its evidence was accepted by the House of Lords Science and Technology Committee, UK Parliament. This was further published in their proceedings- Regenerative Medicine Report by Science and Technology Select Committee, House of Lords, UK.